A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

In this multicenter, open-label, randomized controlled trial, we determined whether 2-month prednisolone therapy for steroid-sensitive nephrotic syndrome was inferior or not to 6-month therapy despite significantly less steroid exposure. The primary end point was time from start of initial treatment...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Kidney Int
Glavni autori: Yoshikawa, Norishige, Nakanishi, Koichi, Sako, Mayumi, Oba, Mari S, Mori, Rintaro, Ota, Erika, Ishikura, Kenji, Hataya, Hiroshi, Honda, Masataka, Ito, Shuichi, Shima, Yuko, Kaito, Hiroshi, Nozu, Kandai, Nakamura, Hidefumi, Igarashi, Takashi, Ohashi, Yasuo, Iijima, Kazumoto
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2015
Teme:
Clinical Trial
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4284810/
https://ncbi.nlm.nih.gov/pubmed/25054775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2014.260
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items